Baker LS - Search Results

1

Effect of antenatal betamethasone administration on placental vascular resistance.

Wallace EM, Baker LS. Wallace EM, et al. Among authors: baker ls. Lancet. 1999 Apr 24;353(9162):1404-7. doi: 10.1016/S0140-6736(98)08229-4. Lancet. 1999. PMID: 10227222

2

Changes in umbilical artery flow velocity waveforms following maternal administration of betamethasone.

Edwards A, Baker LS, Wallace EM. Edwards A, et al. Among authors: baker ls. Placenta. 2003 Jan;24(1):12-6. doi: 10.1053/plac.2002.0874. Placenta. 2003. PMID: 12495654

3

Betamethasone associated changes in umbilical artery flow velocity waveforms in multiple pregnancies with umbilical artery absent end diastolic flow.

Barkehall-Thomas A, Thompson M, Baker LS, Edwards A, Wallace EM. Barkehall-Thomas A, et al. Among authors: baker ls. Aust N Z J Obstet Gynaecol. 2003 Oct;43(5):360-3. doi: 10.1046/j.0004-8666.2003.00104.x. Aust N Z J Obstet Gynaecol. 2003. PMID: 14717312 Clinical Trial.

4

Predicting perinatal outcome through changes in umbilical artery Doppler studies after antenatal corticosteroids in the growth-restricted fetus.

Robertson MC, Murila F, Tong S, Baker LS, Yu VY, Wallace EM. Robertson MC, et al. Among authors: baker ls. Obstet Gynecol. 2009 Mar;113(3):636-640. doi: 10.1097/AOG.0b013e318197bf4d. Obstet Gynecol. 2009. PMID: 19300328

5

Uterine artery Doppler velocimetry for the detection of adverse obstetric outcomes in patients with elevated mid-trimester beta-human chorionic gonadotrophin.

Barkehall-Thomas A, Wilson C, Baker L, ni Bhuinneain M, Wallace EM. Barkehall-Thomas A, et al. Acta Obstet Gynecol Scand. 2005 Aug;84(8):743-7. doi: 10.1111/j.0001-6349.2005.00798.x. Acta Obstet Gynecol Scand. 2005. PMID: 16026398 Free article.

6

Changes in fetoplacental vessel flow velocity waveforms following maternal administration of betamethasone.

Edwards A, Baker LS, Wallace EM. Edwards A, et al. Among authors: baker ls. Ultrasound Obstet Gynecol. 2002 Sep;20(3):240-4. doi: 10.1046/j.1469-0705.2002.00782.x. Ultrasound Obstet Gynecol. 2002. PMID: 12230445 Free article.

7

Maternal serum activin A and the prediction of intrauterine growth restriction.

Barkehall-Thomas A, Tong S, Baker LS, Edwards A, Wallace EM. Barkehall-Thomas A, et al. Among authors: baker ls. Aust N Z J Obstet Gynaecol. 2006 Apr;46(2):97-101. doi: 10.1111/j.1479-828X.2006.00535.x. Aust N Z J Obstet Gynaecol. 2006. PMID: 16638029

8

Optimising the timing for nuchal translucency measurement.

Mulvey S, Baker L, Edwards A, Oldham J, Shekleton P, Wallace EM. Mulvey S, et al. Prenat Diagn. 2002 Sep;22(9):775-7. doi: 10.1002/pd.406. Prenat Diagn. 2002. PMID: 12224069

9

Maternal serum activin A levels in association with intrauterine fetal growth restriction.

Wallace EM, Schneider-Kolsky ME, Edwards A, Baker L, Jenkin G. Wallace EM, et al. BJOG. 2003 Mar;110(3):306-10. BJOG. 2003. PMID: 12628273

10

Accuracy and modifying factors of the sonographic estimation of fetal weight in a high-risk population.

Edwards A, Goff J, Baker L. Edwards A, et al. Aust N Z J Obstet Gynaecol. 2001 May;41(2):187-90. doi: 10.1111/j.1479-828x.2001.tb01206.x. Aust N Z J Obstet Gynaecol. 2001. PMID: 11453269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters